2m 2m 2m 2m 2m 2m 2m
West Pharmaceuti (WST)
NYSE
$336.34+$6.63 (+2.01%)
Price as of Jun 23, 2026 7:05 PM EDT- $23.3BMarket Cap
- 52.65%1-Year Change
- Medical Instruments & SuppliesIndustry
West Pharmaceuti (WST)
$336.34+$6.63 (+2.01%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.1B +6.25% | 2.9B -1.92% | 2.9B +2.18% | 2.9B +1.95% | |
Cost of Revenue | 2.0B +3.98% | 1.9B +4.07% | 1.8B +3.99% | 1.8B +5.73% | |
Gross Profit | 1.1B +10.57% | 998.5M -11.57% | 1.1B -0.62% | 1.1B -3.37% | |
Sales and Marketing Expense | 393.6M +16.28% | 338.5M -4.22% | 353.4M +11.52% | 316.9M -12.65% | |
Research and Development Expense | -74.3M +7.53% | -69.1M +1.02% | -68.4M +16.92% | -58.5M +10.80% | |
Depreciation and Amortization Expense | 168.6M +11.07% | 151.8M +13.54% | 133.7M +14.37% | 116.9M 0.00% | |
Total Operating Expenses | 2.0B +3.98% | 1.9B +4.07% | 1.8B +3.99% | 1.8B +5.73% | |
Operating Profit | 584.9M +2.63% | 569.9M -15.70% | 676.0M -7.90% | 734.0M -2.43% | |
Interest Income | N/A N/A | N/A N/A | -4.3M +22.86% | -3.5M -18.60% | |
Interest Expense | -15.1M -6.79% | -16.2M +80.00% | -9.0M +13.92% | -7.9M -3.66% | |
Interest Income and Expense and Net | -15.1M -6.79% | -16.2M +21.80% | -13.3M +16.67% | -11.4M -8.80% | |
Total Nonoperating Income and Expense | -51.2M +143.81% | -21.0M -33.12% | -31.4M +17.16% | -26.8M +239.24% | |
Income before Taxes | 600.9M +2.63% | 585.5M -16.12% | 698.0M +2.66% | 679.9M -9.21% | |
Income Taxes | 121.6M +13.12% | 107.5M -12.10% | 122.3M +6.63% | 114.7M +7.00% | |
Extraordinary Items | 11.7M +60.27% | 7.3M -23.96% | 9.6M -37.25% | 15.3M N/A | |
Net Income | 493.7M +0.20% | 492.7M -16.97% | 593.4M +1.28% | 585.9M -11.47% | |
Net Income from Continuing Operations Applicable to Common | 493.7M +0.20% | 492.7M -16.97% | 593.4M +1.28% | 585.9M -11.47% | |
Basic EPS and Net Income | 6.83 +1.19% | 6.75 -15.41% | 7.98 +1.40% | 7.87 -11.47% | |
Diluted EPS and Net Income | 6.79 +1.49% | 6.69 -15.10% | 7.88 +1.94% | 7.73 -10.84% | |
Basic Weighted Average Shares | 72.3M -0.96% | 73.0M -1.75% | 74.3M -0.13% | 74.4M 0.00% | |
Diluted Weighted Average Shares | 72.7M -1.36% | 73.7M -2.12% | 75.3M -0.66% | 75.8M -0.66% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 791.3M +63.29% | 484.6M -43.25% | 853.9M -4.52% | 894.3M +17.27% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 791.3M +63.29% | 484.6M -43.25% | 853.9M -4.52% | 894.3M +17.27% | |
Total Current Assets | 2.0B +28.61% | 1.5B -20.57% | 1.9B +0.88% | 1.9B +10.19% | |
Accumulated Depreciation | 1.5B +6.61% | 1.4B +6.00% | 1.3B +7.85% | 1.2B +6.12% | |
Property and Plant and Equipment and Net | 1.7B +9.16% | 1.6B +11.91% | 1.4B +22.02% | 1.2B +9.53% | |
Total Long-Term Assets | 80.1M +7.81% | 74.3M +248.83% | 21.3M -44.09% | 38.1M -2.81% | |
Total Assets | 4.3B +17.20% | 3.6B -4.86% | 3.8B +5.88% | 3.6B +9.14% | |
Income Taxes Payable | 51.1M -1.73% | 52.0M +77.47% | 29.3M -25.06% | 39.1M +25.32% | |
Total Short-Term Debt | 2.3M -4.17% | 2.4M -98.24% | 136.4M +2,865.22% | 4.6M -90.13% | |
Total Current Liabilities | 654.9M +18.99% | 550.4M -18.07% | 671.8M +29.44% | 519.0M -12.64% | |
Total Long-Term Debt | 202.8M +0.10% | 202.6M +178.30% | 72.8M -64.78% | 206.7M -1.01% | |
Total Long-Term Liabilities | 75.2M +20.90% | 62.2M +6.32% | 58.5M +13.37% | 51.6M +35.08% | |
Total Liabilities | 1.1B +13.83% | 961.1M +1.33% | 948.5M +1.78% | 931.9M -4.75% | |
Retained Earnings | 4.4B +10.57% | 4.0B +12.29% | 3.5B +17.93% | 3.0B +21.62% | |
Total Stockholders Equity | 3.2B +18.41% | 2.7B -6.90% | 2.9B +7.30% | 2.7B +14.97% | |
Total Shares Outstanding | 72.0M -0.41% | 72.3M -1.63% | 73.5M -0.81% | 74.1M -0.13% | |
Cash Flow | |||||
Cash from Operating Activities | 754.8M +15.52% | 653.4M -15.85% | 776.5M +7.25% | 724.0M +23.97% | |
Capital Expenditures | 285.9M -24.16% | 377.0M +4.14% | 362.0M +27.20% | 284.6M +12.31% | |
Cash from Investing Activities | -285.9M -24.50% | -378.7M +2.71% | -368.7M +27.93% | -288.2M +13.87% | |
Dividends Paid | 61.2M +3.55% | 59.1M +3.68% | 57.0M +5.36% | 54.1M +5.87% | |
Cash from Financing Activities | -185.1M -70.27% | -622.6M +35.47% | -459.6M +56.54% | -293.6M +74.66% | |
Financials Ratio | |||||
Gross Margin | 35.91% +4.06% | 34.51% -9.84% | 38.28% -2.74% | 39.36% -5.22% | |
Operating Margin | 19.03% -3.41% | 19.70% -14.05% | 22.92% -9.87% | 25.43% -4.30% | |
Return on Assets | 12.48% -5.37% | 13.19% -17.27% | 15.94% -5.73% | 16.91% -21.98% | |
Return on Equity | 16.85% -4.84% | 17.71% -16.93% | 21.32% -8.65% | 23.34% -26.11% | |
Revenue Growth | 6.25% +425.86% | -1.92% -188.07% | 2.18% +11.56% | 1.95% -93.88% | |
Current Ratio | 3.02 +8.09% | 2.79 -3.05% | 2.88 -22.07% | 3.70 +26.13% | |
Cash Ratio | 1.21 +37.23% | 0.88 -30.73% | 1.27 -26.23% | 1.72 +34.24% | |
Debt-to-Equity Ratio | 0.06 -15.45% | 0.08 +5.23% | 0.07 -7.75% | 0.08 -28.06% | |
Debt-to-Assets Ratio | 0.05 -14.74% | 0.06 +3.11% | 0.05 -6.51% | 0.06 -24.25% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow